< Back to previous page
Researcher
Michiel Remmerie
- Disciplines:Cancer biology
Affiliations
- Laboratory of Protein Phosphorylation and Proteomics (Division)
Member
From28 Aug 2017 → Today
Projects
1 - 1 of 1
- PPP2R1A as a new treatment biomarker in tpe II serous endometrial cancers: a pre-clinical proof-of-concept studyFrom1 Jan 2018 → 26 Jun 2024Funding: FWO Strategic Basic Research Grant
Publications
1 - 6 of 6
- The PPP2R1A cancer hotspot mutant p.R183W increases clofarabine resistance in uterine serous carcinoma cells by a gain-of-function mechanism(2024)Published in: Cellular OncologyISSN: 2211-3428Issue: 5Volume: 47
- PPP2R1A mutations in uterine serous carcinoma: exploring the role and predictive marker potential of hotspot mutant p.R183W(2024)
- A Novel Mouse Model of Combined Hepatocellular-Cholangiocarcinoma Induced by Diethylnitrosamine and Loss of Ppp2r5d(2023)Published in: CancersISSN: 2072-6694Issue: 16Volume: 15
- PP2A: A Promising Biomarker and Therapeutic Target in Endometrial Cancer(2019)Published in: Frontiers in OncologyISSN: 2234-943XVolume: 9
- Targeted Therapies in Type II Endometrial Cancers: Too Little, but Not Too Late.(2018)Published in: International Journal of Molecular SciencesISSN: 1422-0067Issue: 8Volume: 19
- Deficiency of the thyroid hormone transporter Monocarboxylate Transporter 8 in neural progenitors impairs cellular processes crucial for early corticogenesis(2017)Published in: Journal of NeuroscienceISSN: 0270-6474Issue: 48Volume: 37Pages: 11616 - 11631